Cargando…
PB2171: THE NOVEL CSN5/JAB1 INHIBITOR CSN5I-3 SUPPRESSES CELL GROWTH AND UPREGULATES GENE EXPRESSION OF TYPE-I INTERFERONS (IFN) IN ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
Autores principales: | Xagoraris, I., Kokaraki, G., Stathopoulou, K., Claret, F. X., Drakos, E., Rassidakis, G. Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431386/ http://dx.doi.org/10.1097/01.HS9.0000851512.38504.a0 |
Ejemplares similares
-
P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022) -
Stat3 Contributes to Cancer Progression by Regulating Jab1/Csn5 Expression
por: Pan, Yunbao, et al.
Publicado: (2016) -
JAB1/CSN5: a new player in cell cycle control and cancer
por: Shackleford, Terry J, et al.
Publicado: (2010) -
Suppression of Jab1/CSN5 induces radiation- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways
por: Pan, Yunbao, et al.
Publicado: (2012) -
Identification of a seven-long non-coding RNA signature associated with Jab1/CSN5 in predicting hepatocellular carcinoma
por: Ma, Weijie, et al.
Publicado: (2021)